PSM Inc.

Portela Soni Medical (PSM) is a biotechnology and healthcare startup that aims to reduce infections through innovative improvements to the age-old urinary catheter. Founded in 2014, the company is dedicated to enhancing patient outcomes by minimizing the risk of infections, particularly for elderly individuals in hospitals or nursing homes. PSM's urinary catheter is currently in the research and development phase, with plans to file for FDA 510(k) approval in 2018. In March 2018, PSM successfully secured a $400.00K investment in a Seed Round, signaling confidence in their vision and technological advancements. Despite not disclosing specific investors, it is evident that external parties recognize the potential of PSM's innovative approach to addressing infectious complications associated with urinary catheters. As the company continues to advance its groundbreaking solutions, it presents an opportunity for venture capital firms seeking to support impactful advancements in the biotechnology and healthcare sectors. PSM's focus on reducing infections aligns with the growing emphasis on patient safety and quality healthcare delivery, further enhancing its appeal to potential investors. With a mission-centric approach and a clear commitment to revolutionizing patient care, PSM presents an intriguing investment prospect within the healthcare innovation landscape. As the company progresses towards obtaining FDA approval and commercializing its urinary catheter technology, it represents a compelling opportunity for venture capital participation in pioneering healthcare solutions.